Advertisement

Calcified Tissue International

, Volume 101, Issue 4, pp 362–370 | Cite as

Muscle Function in Osteogenesis Imperfecta Type IV

  • Louis-Nicolas VeilleuxEmail author
  • Vasiliki B. Darsaklis
  • Kathleen Montpetit
  • Francis H. Glorieux
  • Frank Rauch
Original Research

Abstract

Results of previous studies suggest that children and adolescents with osteogenesis imperfecta (OI) type IV have muscle force deficits. However, muscle function remains to be objectively quantified in this population. This study aimed to assess upper and lower extremity muscle function in patients with OI type IV. It was carried out in the outpatient department of a pediatric orthopedic hospital; 27 individuals with OI type IV (7–21 years; 13 males), 27 age- and sex-matched individuals with OI type I, and 27 age- and sex-matched controls. Upper extremity muscle force was assessed with hydraulic hand dynamometry, and lower extremity muscle function (peak force per body weight and peak power per body mass) was measured by mechanography through five tests: multiple two-legged hopping, multiple one-legged hopping, single two-legged jump, chair-rise test, and heel-rise test. Upper-limb grip force was normal for patients with OI type IV when compared to height and sex reference data (average z-score = 0.17 ± 1.30; P = 0.88). Compared to age- and sex-matched controls, patients with OI type IV had approximately 30% lower-limb peak force and 50% peak power deficits (P values <0.05). At the lower-limb level, they had a 50% lower peak power than age- and sex-matched patients with OI type I (P < 0.05). Patients with OI type IV have normal upper-limb muscle force but a muscle function deficit at the lower-limb level. These results suggest that lower-limb muscle weakness may contribute to functional deficits in these individuals.

Keywords

Osteogenesis imperfect Mechanography Maximum isometric grip force Upper-limb muscle force Lower-limb muscle function Muscle power 

Notes

Acknowledgements

This study was supported by the Shriners International. F.R. received salary support from the Chercheur-Boursier Clinicien program of the Fonds de Recherche du Québec—Santé. L.N.V. received postdoctoral fellowships from the Fonds de la Recherche du Québec—Santé and the MENTOR-RSBO (Network for Oral and Bone Health Research), supported by the Canadian Institutes of Health Research (MENTOR) and the Fonds de la Recherche du Québec—Santé (RSBO). The funding agencies were not involved in the design of the study, collection, analysis, and interpretation of data and in writing the manuscript.

Author’s Contribution

Veilleux LN conceptualized and designed the study, carried out the analyses, drafted the initial manuscript. He is the guarantor. Darsaklis VB participated in data collection and interpretation. Montpetit K participated in data collection and interpretation. Glorieux FH contributed patient information and participated in the interpretation of data. Rauch F contributed patient information, conceptualized and designed the study and participated in the interpretation of data. All authors revised the paper critically for intellectual content and approved the final version. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.

Compliance with Ethical Standards

Conflicts of interest

The authors declare that there are no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Human and Animal Rights and Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from study participants or the legal guardians.

References

  1. 1.
    Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377–1385. doi: 10.1016/S0140-6736(04)16051-0 CrossRefPubMedGoogle Scholar
  2. 2.
    Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Veilleux LN, Lemay M, Pouliot-Laforte A, Cheung MS, Glorieux FH, Rauch F (2014) Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I. J Clin Endocrinol Metab 99:E356–E362. doi: 10.1210/jc.2013-3209 CrossRefPubMedGoogle Scholar
  4. 4.
    Veilleux LN, Pouliot-Laforte A, Lemay M, Cheung MS, Glorieux FH, Rauch F (2015) The functional muscle-bone unit in patients with osteogenesis imperfecta type I. Bone 79:52–57. doi: 10.1016/j.bone.2015.05.019 CrossRefPubMedGoogle Scholar
  5. 5.
    Graf A, Hassani S, Krzak J, Caudill A, Flanagan A, Bajorunaite R et al (2009) Gait characteristics and functional assessment of children with type I osteogenesis imperfecta. J Orthop Res 27:1182–1190. doi: 10.1002/jor.20871 CrossRefPubMedGoogle Scholar
  6. 6.
    Caudill A, Flanagan A, Hassani S, Graf A, Bajorunaite R, Harris G et al (2010) Ankle strength and functional limitations in children and adolescents with type I osteogenesis imperfecta. Pediatr Phys Ther. 22:288–295. doi: 10.1097/PEP.0b013e3181ea8b8d CrossRefPubMedGoogle Scholar
  7. 7.
    Takken T, Terlingen HC, Helders PJ, Pruijs H, Van der Ent CK, Engelbert RH (2004) Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J Pediatr 145:813–818. doi: 10.1016/j.jpeds.2004.08.003 CrossRefPubMedGoogle Scholar
  8. 8.
    Van Brussel M, Takken T, Uiterwaal CS, Pruijs HJ, Van der Net J, Helders PJ et al (2008) Physical training in children with osteogenesis imperfecta. J Pediatr 152:111–116. doi: 10.1016/j.jpeds.2007.06.029 CrossRefPubMedGoogle Scholar
  9. 9.
    Montpetit K, Palomo T, Glorieux FH, Fassier F, Rauch F (2015) Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity. Arch Phys Med Rehabil 96:1834–1839. doi: 10.1016/j.apmr.2015.06.006 CrossRefPubMedGoogle Scholar
  10. 10.
    Palomo T, Glorieux FH, Schoenau E, Rauch F (2016) Body composition in children and adolescents with osteogenesis imperfecta. J Pediatr 169:232–237. doi: 10.1016/j.jpeds.2015.10.058 CrossRefPubMedGoogle Scholar
  11. 11.
    Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P et al (2000) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650–1658. doi: 10.1359/jbmr.2000.15.9.1650 CrossRefPubMedGoogle Scholar
  12. 12.
    Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38. doi: 10.1359/jbmr.2002.17.1.30 CrossRefPubMedGoogle Scholar
  13. 13.
    Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L et al (2002) Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 31:12–18CrossRefPubMedGoogle Scholar
  14. 14.
    Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R et al (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60CrossRefPubMedGoogle Scholar
  15. 15.
    Rauch F, Neu CM, Wassmer G, Beck B, Rieger-Wettengl G, Rietschel E et al (2002) Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics. Pediatr Res 51:505–510. doi: 10.1203/00006450-200204000-00017 CrossRefPubMedGoogle Scholar
  16. 16.
    Feldman AB, Haley SM, Coryell J (1990) Concurrent and construct validity of the pediatric evaluation of disability inventory. Phys Ther 70:602–610CrossRefPubMedGoogle Scholar
  17. 17.
    Bleck EE (1981) Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management. Clin Orthop Relat Res. 159:111–122Google Scholar
  18. 18.
    Veilleux LN, Rauch F (2010) Reproducibility of jumping mechanography in healthy children and adults. J Musculoskelet Neuronal Interact 10:256–266PubMedGoogle Scholar
  19. 19.
    Anliker E, Rawer R, Boutellier U, Toigo M (2011) Maximum ground reaction force in relation to tibial bone mass in children and adults. Med Sci Sports Exerc 43:2102–2109. doi: 10.1249/MSS.0b013e31821c4661 CrossRefPubMedGoogle Scholar
  20. 20.
    Foldvari M, Clark M, Laviolette LC, Bernstein MA, Kaliton D, Castaneda C et al (2000) Association of muscle power with functional status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci 55:M192–M199CrossRefPubMedGoogle Scholar
  21. 21.
    Mathiowetz V, Wiemer DM, Federman SM (1986) Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther 40:705–711CrossRefPubMedGoogle Scholar
  22. 22.
    Sumnik Z, Matyskova J, Hlavka Z, Durdilova L, Soucek O, Zemkova D (2013) Reference data for jumping mechanography in healthy children and adolescents aged 6–18 years. J Musculoskelet Neuronal Interact 13:297–311PubMedGoogle Scholar
  23. 23.
    Tosi LL, Oetgen ME, Floor MK, Huber MB, Kennelly AM, McCarter RJ et al (2015) Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis. 10:146. doi: 10.1186/s13023-015-0362-2 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Misof K, Landis WJ, Klaushofer K, Fratzl P (1997) Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest. 100:40–45. doi: 10.1172/JCI119519 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Brizola E, Staub AL, Felix TM (2014) Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta. Pediatr Phys Ther. 26:245–252. doi: 10.1097/PEP.0000000000000042 CrossRefPubMedGoogle Scholar
  26. 26.
    Sims TJ, Miles CA, Bailey AJ, Camacho NP (2003) Properties of collagen in OIM mouse tissues. Connect Tissue Res 44(Suppl 1):202–205CrossRefPubMedGoogle Scholar
  27. 27.
    Gillies AR, Lieber RL (2011) Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve 44:318–331. doi: 10.1002/mus.22094 PubMedPubMedCentralGoogle Scholar
  28. 28.
    Huijing PA (1999) Muscle as a collagen fiber reinforced composite: a review of force transmission in muscle and whole limb. J Biomech 32:329–345CrossRefPubMedGoogle Scholar
  29. 29.
    Murphy A, Wilson G (1996) Poor correlations between isometric tests and dynamic performance: relationship to muscle activation. Eur J Appl Physiol Occup Physiol. 73:353–357. doi: 10.1007/bf02425498 CrossRefPubMedGoogle Scholar
  30. 30.
    Matheson LA, Duffy S, Maroof A, Gibbons R, Duffy C, Roth J (2013) Intra- and inter-rater reliability of jumping mechanography muscle function assessments. J Musculoskelet Neuronal Interact 13:480–486PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Motion Analysis CenterShriners Hospital for Children-CanadaMontrealCanada
  2. 2.Clinical Research DepartmentShriners Hospital for Children-CanadaMontrealCanada
  3. 3.Genetic and Metabolic UnitShriners Hospital for Children-CanadaMontrealCanada
  4. 4.Department of KinesiologyUniversité de MontréalMontrealCanada
  5. 5.Faculty of MedicineMcGill UniversityMontrealCanada

Personalised recommendations